Digital Reuters Pharma Europe 2024 – Day Three As Reuters Pharma Europe 2024 comes to a close in Barcelona, pharmaphorum remains on site to live blog the last remaining talks and insights.
Digital Under the skin of innovation LEO’s Innovation Lab is working at arm’s length from the main company to encourage original thinking and develop cutting edge tech for dermatology.
Articles Stop being control freaks: pharma’s challenge in involving p... Lode Dewulf, chief patient affairs officer at UCB, tells Paul Tunnah how patient-centricity is evolving, and describes how pharma still needs to adapt.
Articles Patientcentricity: is pharma making progress? 8 insights fr... Pharma is moving towards greater patientcentricity – but there are plenty of obstacles and commercial pressures remaining, reports Andrew McConaghie.
Articles Tunnah’s musings: Six pharma trends from eyeforpharma Barcel... An ominous sign that eyeforpharma Barcelona was in its 13th year last week?
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
